81 related articles for article (PubMed ID: 12050731)
1. [The role of syndecans in lymphoid systems].
Sebestyén A; Kopper L
Magy Onkol; 2001; 45(1):67-74. PubMed ID: 12050731
[TBL] [Abstract][Full Text] [Related]
2. Syndecans and the lymphoid system.
Kopper L; Sebestyén A
Leuk Lymphoma; 2000 Jul; 38(3-4):271-81. PubMed ID: 10830734
[TBL] [Abstract][Full Text] [Related]
3. Syndecan-1 in B lymphoid malignancies.
Sanderson RD; Børset M
Ann Hematol; 2002 Mar; 81(3):125-35. PubMed ID: 11904737
[TBL] [Abstract][Full Text] [Related]
4. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
[TBL] [Abstract][Full Text] [Related]
5. Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells.
Dobra K; Nurminen M; Hjerpe A
Anticancer Res; 2003; 23(3B):2435-44. PubMed ID: 12894525
[TBL] [Abstract][Full Text] [Related]
6. The role of syndecan-4 and attached glycosaminoglycan chains on myogenic satellite cell growth.
Zhang X; Nestor KE; McFarland DC; Velleman SG
Matrix Biol; 2008 Sep; 27(7):619-30. PubMed ID: 18602469
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
Winkler S; Stahl RC; Carey DJ; Bansal R
J Neurosci Res; 2002 Aug; 69(4):477-87. PubMed ID: 12210841
[TBL] [Abstract][Full Text] [Related]
8. [Syndecans in cell adhesion and differentiation].
Brzóska E; Grabowska I
Postepy Biochem; 2005; 51(1):52-9. PubMed ID: 16209342
[TBL] [Abstract][Full Text] [Related]
9. Syndecans in wound healing, inflammation and vascular biology.
Alexopoulou AN; Multhaupt HA; Couchman JR
Int J Biochem Cell Biol; 2007; 39(3):505-28. PubMed ID: 17097330
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas.
Sebestyén A; Berczi L; Mihalik R; Paku S; Matolcsy A; Kopper L
Br J Haematol; 1999 Feb; 104(2):412-9. PubMed ID: 10050727
[TBL] [Abstract][Full Text] [Related]
11. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
12. The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.
Brule S; Charnaux N; Sutton A; Ledoux D; Chaigneau T; Saffar L; Gattegno L
Glycobiology; 2006 Jun; 16(6):488-501. PubMed ID: 16513763
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate proteoglycans are increased during skeletal muscle regeneration: requirement of syndecan-3 for successful fiber formation.
Casar JC; Cabello-Verrugio C; Olguin H; Aldunate R; Inestrosa NC; Brandan E
J Cell Sci; 2004 Jan; 117(Pt 1):73-84. PubMed ID: 14627628
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-2 downregulation impairs angiogenesis in human microvascular endothelial cells.
Noguer O; Villena J; Lorita J; Vilaró S; Reina M
Exp Cell Res; 2009 Mar; 315(5):795-808. PubMed ID: 19073173
[TBL] [Abstract][Full Text] [Related]
15. Influence of cytoplasmic deletions on the filopodia-inducing effect of syndecan-3.
Berndt C; Montañez E; Villena J; Fabre M; Vilaró S; Reina M
Cell Biol Int; 2004; 28(11):829-33. PubMed ID: 15563406
[TBL] [Abstract][Full Text] [Related]
16. [Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma].
Péterfia B; Hollósi P; Szilák L; Timár F; Paku S; Jeney A; Kovalszky I
Magy Onkol; 2006; 50(2):115-20. PubMed ID: 16888674
[TBL] [Abstract][Full Text] [Related]
17. [Proteoglycans in the liver].
Kovalszky I; Dudás J; Gallai M; Hollósi P; Tátrai P; Tátrai E; Schaff Z
Magy Onkol; 2004; 48(3):207-13. PubMed ID: 15520870
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwann cells.
Asundi VK; Erdman R; Stahl RC; Carey DJ
J Neurosci Res; 2003 Sep; 73(5):593-602. PubMed ID: 12929127
[TBL] [Abstract][Full Text] [Related]
20. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
